USPTO serial 79274176
ORICIRO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 17, 2020
- Examiner
- STEDMAN, CORI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ORICIRO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,295*
Plus Government fees of $1,625
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sandra Epp Ryan
Sandra Epp Ryan Hamre, Schumann, Mueller & Larson, P.C.45 S. 7th St., Ste. 2700Minneapolis, MN 55402UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical reagents for genetic research, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; reagents for scientific and research use, namely, for DNA amplification; reagents for genetic research purposes, other than for medical or veterinary purposes; reagents for research purposes; reagents for scientific purposes for use in nucleic acid isolation and purification; reagents for scientific purposes; chemicals for use in the manufacture of pharmaceuticals; industrial chemicals; test paper, chemical; reagent paper, other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Chemical reagents for medical purposes; diagnostic reagents for medical purposes; reagents for use in medical genetic testing; reagents, for medical purposes; diagnostic preparations for medical purposes; pharmaceutical preparations, for the treatment of diseases caused by genetic disorder; reagent paper for medical purposes | ACTIVE | — |
| 009 | Genetic specimen samplers, other than for medical use, namely, testing sample collection equipment in the nature of wipes and swabs for use in diagnostic testing, not for medical purposes; DNA chips; DNA chip making apparatus being a DNA microarray apparatus; DNA synthesizing apparatus, namely, DNA microarray; DNA analyzing apparatus, namely, laboratory research instruments for DNA analysis; scientific apparatus and instruments and laboratory apparatus for research purposes, namely, polymerase chain reaction thermocyclers used to amplify DNA, for analytical and research purposes; DNA fragmentation apparatus, namely, laboratory apparatus to separate or for breaking DNA strands into pieces; gene testing equipment for research purposes, namely, electrical equipment for the genetic modification of cells for research purposes; analytical apparatus, namely, laboratory apparatus for extracting DNA for use in laboratory; laboratory kits for use with reagents for DNA amplification comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; laboratory kits for use with reagents for genetic research comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; laboratory apparatus and instruments in the form of kits comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; measuring or testing machines and instruments, namely, scientific apparatus and instruments for measuring relative DNA, RNA and protein | ACTIVE | — |
| 040 | Custom treatment of materials in the nature of syntheses of DNA; custom treatment of materials in the nature of syntheses of RNA; custom treatment of materials in the nature of syntheses of nucleic acids; custom treatment of materials in the nature of amplification of DNA; custom manufacture of chemicals; processing of chemical reagents; processing of medicinal materials, namely, medicinal plants; custom manufacture, namely, extraction, purification and syntheses of pharmaceuticals; custom manufacture of pharmaceuticals; treatment of biopharmaceutical materials by means of DNA engineering; providing material treatment information | ACTIVE | — |
| 042 | Testing, inspection, research or development services in the fields of genes, namely, research in the fields of genetics, gene therapy, DNA and chemical and biological production methods; consultancy and information services relating to testing, inspection, research or development services in the fields of genes, namely, scientific research consulting in the fields of genetics, gene therapy, DNA and chemical and biological production methods; scientific research in the fields of genetics and genetic engineering; testing, inspection, research or development services in the fields of chemistry, namely, scientific research and development in the fields of chemistry; consultancy and information services relating to testing, inspection, research or development services in the fields of chemistry, namely, chemistry consultation; testing, inspection, research or development services in the fields of pharmaceuticals, namely, testing, inspection, research, or development of pharmaceutical preparations for gene therapy including DNA and RNA-based therapy and vaccines; consultancy and information services relating to testing, inspection, research or development services in the fields of pharmaceuticals, namely, scientific research consulting in the fields of pharmaceuticals; testing, inspection or research on agriculture, livestock breeding or fisheries; testing or research on prevention of pollution; scientific laboratory services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by OriCiro Genomics, Inc.
- Other trademarks owned by OriCiro Genomics, Inc.
- Other trademarks owned by OriCiro Genomics, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named ORICIRO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 17, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 20, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 20, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jan 20, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 20, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 21, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 26, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 26, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 17, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 11, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 17, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 1, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 1, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 12, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 24, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 23, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 22, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 22, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 8, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 23, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 23, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 24, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 24, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 23, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 20, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 20, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 19, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |